Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antiviral Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1244588C details a novel PDC oxidation route for C10 sugars from xylose, offering cost-effective antiviral intermediate synthesis.
Patent CN101671333B reveals a novel resin-based separation method for emtricitabine, ensuring high purity and cost-effective scale-up for global pharmaceutical manufacturers.
Patent CN115286584A reveals a novel synthesis route for 2,4,5-triamino-6-hydroxypyrimidine sulfate, offering significant cost reduction and waste minimization for API manufacturers.
Advanced chiral resolution technology for 2-heterocyclic dihydropyrimidines using binaphthol phosphate. Delivers >99% optical purity for scalable hepatitis B drug manufacturing.
Patent CN114031542A reveals a green Cu-catalyzed cyclization route for 6,6-dimethyl-3-azabicyclo[3.1.0]hexane, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN103755667A reveals a novel organocatalytic route for chiral tetrahydrofurans, offering superior enantioselectivity and scalable manufacturing for global API supply chains.
Patent CN112110969B details a novel route for 3-nitro-7-azaindole triazole glycosides. Discover cost-effective synthesis and supply chain advantages for oncology APIs.
Discover the novel synthesis of 3-nitro-7-azaindole triazole glycosides. A scalable, metal-free route for antiviral and anticancer pharmaceutical intermediates with improved solubility.
Patent CN1878782A reveals a scalable route for L-nucleoside precursors using 2-deoxy-D-galactose. Achieve cost reduction in antiviral drug manufacturing with high purity.
Patent CN101200463B details a cost-effective D-glucose route for 4-thio-D-ribose intermediates, offering significant supply chain advantages over traditional L-lyxose methods.
Novel route from D-glucose reduces cost for 4-thio-nucleoside intermediates. High purity scalable process for antiviral drug synthesis.
Novel synthesis of Reidesciclovir intermediate via ammonium sulfate cyclization offers high purity and scalable manufacturing for global pharmaceutical supply chains.
Novel synthesis route for 2-deoxy-D-glucose via glucosamine. Reduces cost and complexity. Ideal for API manufacturing scale-up and high-purity production.
Patent CN113912577A details a novel dual-catalytic asymmetric allylation for high-purity Rocaglaol intermediates, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Optimized synthesis route for Tenofovir Alafenamide reduces costs and improves chirality. Reliable supply chain partner for high-purity pharmaceutical intermediates manufacturing.
Patent CN1111531C details a scalable xylene-based process for castanospermine esters, offering significant cost reduction in pharma manufacturing and enhanced supply reliability.
Patent CN113429445A details a novel isoxazole-arabinose triazole synthesis. Discover cost-effective manufacturing and high-purity supply for oncology antiviral intermediates.
Patent CN102108069A details a mild, scalable route for 6-benzothiazole sulfonyl chloride. Discover cost-effective manufacturing for HIV inhibitor intermediates.
Patent CN112159360B details a green ruthenium-catalyzed route for triazine derivatives, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Advanced synthesis of oseltamivir phosphate via improved tert-butyl removal. Cost-effective route using sulfuric acid reduces waste and enhances supply chain reliability for API manufacturing.